On Invalid Date, Bio Rad Laboratories (NYSE: BIO) reported Q4 2023 earnings per share (EPS) of $11.81, up 57.24% year over year. Total Bio Rad Laboratories earnings for the quarter were $349.71 million. In the same quarter last year, Bio Rad Laboratories's earnings per share (EPS) was $27.62.
As of Q2 2024, Bio Rad Laboratories's earnings has grown year over year. Bio Rad Laboratories's earnings in the past year totalled -$637.32 million.
What is BIO's earnings date?
Bio Rad Laboratories's earnings date is Invalid Date. Add BIO to your watchlist to be reminded of BIO's next earnings announcement.
What was BIO's revenue last quarter?
On Invalid Date, Bio Rad Laboratories (NYSE: BIO) reported Q4 2023 revenue of $681.18 million up 6.72% year over year. In the same quarter last year, Bio Rad Laboratories's revenue was $730.29 million.
What was BIO's revenue growth in the past year?
As of Q2 2024, Bio Rad Laboratories's revenue has grown -4.67% year over year. This is 13.93 percentage points lower than the US Medical Devices industry revenue growth rate of 9.25%. Bio Rad Laboratories's revenue in the past year totalled $2.67 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.